Table 4 Novel network genes
Gene ID | Gene name | RA vs. CONTROL | |
|---|---|---|---|
Fold change | p value | ||
BTF3 | Basic transcription factor 3 | 1.11 | 0.003 |
CTDP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 | −1.04 | 0.006 |
DDRGK1 | DDRGK domain containing 1 | −1.07 | 0.02 |
DIO1 | Deiodinase, iodothyronine, type I | 1.03 | 0.005 |
EDARADD | EDAR-associated death domain | −1.06 | 0.007 |
EIF2AK1 | Eukaryotic translation initiation factor 2-alpha kinase 1 | 1.05 | 0.007 |
FKBPL | FK506 binding protein like | −1.06 | 0.003 |
GUCY2D | Guanylate cyclase 2D, membrane (retina-specific) | −1.04 | 0.004 |
IFT57 | Intraflagellar transport 57 | 1.04 | 0.01 |
IRAK1BP1 | Interleukin-1 receptor-associated kinase 1 binding protein 1 | 1.02 | 0.02 |
KMT2C | Lysine (K)-specific methyltransferase 2C | 1.03 | 0.01 |
LAMB1 | Laminin, beta 1 | 1.11 | 0.02 |
MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | −1.03 | 0.008 |
MYL4 | Myosin, light chain 4, alkali; atrial, embryonic | 1.02 | 0.01 |
NFkB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p52/p100) | −1.06 | 0.003 |
NOP14 | NOP14 nucleolar protein | −1.08 | 0.008 |
OGG1 | 8-Oxoguanine DNA glycosylase | 1.03 | 0.002 |
PKD2 | Polycystic kidney disease 2 (autosomal dominant) | 1.05 | 0.02 |
POLR2J2/POLR2J3 | Polymerase (RNA) II (DNA directed) polypeptide J3 | 1.08 | 0.004 |
PPP4R4 | Protein phosphatase 4, regulatory subunit 4 | 1.03 | 0.006 |
RHOH | Ras homolog family member H | −1.06 | 0.002 |
S100B | S100 calcium binding protein B | 1.02 | 0.02 |
SCIN | Scinderin | 1.04 | 0.001 |
STC2 | Stanniocalcin 2 | 1.04 | 0.008 |
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250Â kDa | 1.04 | 0.02 |
TNFRSF12A | Tumor necrosis factor receptor superfamily, member 12A; TNF-like weak inducer of apoptosis (TWEAK) receptor | 1.24 | 0.01 |
TNFRSF18 | Tumor necrosis factor receptor superfamily, member 18 | −1.02 | 0.005 |